Epidemiological Trends in Head and Neck Cancer and Aids in Diagnosis

By N. Vigneswaran, M. Williams. Oral and Maxillofacial Surgery Clinics of North America, 2014

771 citations recorded by the source corpus.

Head and neck squamous cell carcinoma is the sixth most common cancer worldwide predominately associated with tobacco use. Changing cause and increased incidence in oropharyngeal carcinomas is associated with high-risk types of human papilloma virus and has an improved survival. Optical devices may augment visual oral examination; however, their lack of specificity still warrants tissue evaluation/biopsy. Histologic factors of oral carcinomas are critical for patient management and prognostic determination. Clinical biomarkers are still needed to improve early detection, predict malignant transformation, and optimize therapies.

Subfields: Otorhinolaryngology, Periodontics, Surgery

View Paper: https://www.semanticscholar.org/paper/3eba1a6d7487033abac2db31c0c0f3876560126b

Citations in the corpus

• Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression (2018, neutral): “Squamous cell carcinoma of the head and neck (SCCHN) includes neoplasms in the oral cavity, pharynx, and larynx, and accounts for 90% of all head and neck cancers [1-3].”